person · Reporting owner
Klasko Stephen K. M.D.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DocGo Inc.DCGO · Entity 7359 | Director | September 10, 2025 | September 11, 2025 |
| Health Assurance Acquisition Corp.HAAC · Entity 122106 | Director | November 12, 2020 | November 12, 2020 |
| TELEFLEX INCTFX · Entity 3798 | Director | May 09, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DocGo Inc.
Report date September 10, 2025 · Filed September 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,000 |
Reported balance
After 2025-09-10 transaction · row 1
1 source rowRow 1 · 2025-09-10 · Grant · Acquired 100,000 · Balance 115,000 F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on September 10, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on September 10, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
Health Assurance Acquisition Corp.
Report date November 12, 2020 · Filed November 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B common stockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-11-12 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-249667), as amended, under the heading "Description of Securities-Alignment Shares", the shares of Class B common stock, par value $0.0001, will convert into shares of Class A common stock, par value $0.0001, pursuant to the performance of publicly traded shares of Class A common stock of the issuer after the consummation of the issuer's initial business combination. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-249667), as amended, under the heading "Description of Securities-Alignment Shares", the shares of Class B common stock, par value $0.0001, will convert into shares of Class A common stock, par value $0.0001, pursuant to the performance of publicly traded shares of Class A common stock of the issuer after the consummation of the issuer's initial business combination.
TELEFLEX INC
Report date May 09, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,332.55 |
Reported balance
After 2025-05-09 transaction · row 1
1 source rowRow 1 · 2025-05-09 · Grant · Acquired 1,357 · Balance 9,332.55 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $125.11 · Expires 2035-05-09 | Direct | 2,226 |
Reported balance
After 2025-05-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-05-09 · Grant · Acquired 2,226 · Balance 2,226 F2: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. |
| Common StockSEC Table I · non-derivative | IndirectBy Stephen K. Klasko Revocable Trust | 7,880 |
Reported balance
Holding disclosure · report date 2025-05-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,880 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders.
F2: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2025 Filed Sep 11, 2025 17:20 UTC | DocGo Inc. DCGO · Entity 7359 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-086890 · ownership.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,000 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on September 10, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| May 14, 2025 Filed May 14, 2025 17:42 UTC | DocGo Inc. DCGO · Entity 7359 | PurchaseCommon Stock | 15,000 | $1.49 | $22,350.00 |
DisclosureSEC source: 0001822359-25-000050 · wk-form4_1747258953.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.54. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 2,226 | $0.00 Strike: $125.11 | $0.00 |
DisclosureSEC source: 0000096943-25-000090 · wk-form4_1747170141.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,226 Underlying: Common Stock · 2,226 shares Expires 2035-05-09 F2 · derivative.exercise_date: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-25-000090 · wk-form4_1747170141.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,332.55 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 23:09 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 2,674 | $0.00 Strike: $121.00 | $0.00 |
DisclosureSEC source: 0000096943-25-000002 · wk-form4_1740179354.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,674 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 23:09 UTC | TELEFLEX INC TFX · Entity 3798 | Tax withholdingCommon Stock | 1,851 | $174.82 | $323,591.82 |
DisclosureSEC source: 0000096943-25-000002 · wk-form4_1740179354.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,975.55 Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 23:09 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 2,674 | $121.00 | $323,554.00 |
DisclosureSEC source: 0000096943-25-000002 · wk-form4_1740179354.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826.55 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 17:23 UTC | DocGo Inc. DCGO · Entity 7359 | GrantOptions to purchase Common Stock · Derivative | 204,082 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0001822359-24-000096 · wk-form4_1731623008.xml · derivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,082 Underlying: Common Stock · 204,082 shares Expires 2034-11-12 F1 · shares: Represents options granted under the DocGo Inc. 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock. F2 · derivative.exercise_date: The reported options will vest and become exercisable on the first anniversary of the grant date, subject to the terms of the Plan. Read SEC document |
| May 07, 2024 Filed May 9, 2024 23:01 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 1,349 | $0.00 Strike: $201.52 | $0.00 |
DisclosureSEC source: 0000096943-24-000088 · wk-form4_1715295694.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,349 Underlying: Common Stock · 1,349 shares Expires 2034-05-07 F2 · derivative.exercise_date: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2025 annual meeting of stockholders (the "2025 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2025 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2024 annual meeting of stockholders. Read SEC document |
| May 07, 2024 Filed May 9, 2024 23:01 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 838 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-24-000088 · wk-form4_1715295694.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,137.136 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2025 annual meeting of stockholders (the "2025 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2025 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2024 annual meeting of stockholders. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:21 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 3,021 | $0.00 Strike: $101.12 | $0.00 |
DisclosureSEC source: 0000096943-23-000106 · wk-form4_1702678893.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,021 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:21 UTC | TELEFLEX INC TFX · Entity 3798 | Tax withholdingCommon Stock | 1,296 | $235.89 | $305,713.44 |
DisclosureSEC source: 0000096943-23-000106 · wk-form4_1702678893.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,288.462 Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:21 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 3,021 | $101.12 | $305,483.52 |
DisclosureSEC source: 0000096943-23-000106 · wk-form4_1702678893.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,584.462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2023 Filed May 11, 2023 21:46 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 1,076 | $0.00 Strike: $251.99 | $0.00 |
DisclosureSEC source: 0000096943-23-000062 · wf-form4_168384156798187.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076 Underlying: Common Stock · 1,076 shares Expires 2033-05-09 Read SEC document |
| May 09, 2023 Filed May 11, 2023 21:46 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-23-000062 · wf-form4_168384156798187.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,563.462 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on May 9, 2024. Read SEC document |
| January 27, 2023 Filed Jan 27, 2023 23:12 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 3,014 | $0.00 Strike: $78.50 | $0.00 |
DisclosureSEC source: 0000096943-23-000008 · wf-form4_167486111106188.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,014 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2023 Filed Jan 27, 2023 23:12 UTC | TELEFLEX INC TFX · Entity 3798 | Tax withholdingCommon Stock | 967 | $244.68 | $236,605.56 |
DisclosureSEC source: 0000096943-23-000008 · wf-form4_167486111106188.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,882.462 Read SEC document |
| January 27, 2023 Filed Jan 27, 2023 23:12 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 3,014 | $78.50 | $236,599.00 |
DisclosureSEC source: 0000096943-23-000008 · wf-form4_167486111106188.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,849.462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2022 Filed May 5, 2022 00:04 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 969 | $0.00 Strike: $284.85 | $0.00 |
DisclosureSEC source: 0000096943-22-000055 · wf-form4_165170899397651.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969 Underlying: Common Stock · 969 shares Expires 2032-05-03 Read SEC document |
| May 03, 2022 Filed May 5, 2022 00:04 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 399 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-22-000055 · wf-form4_165170899397651.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,827.54 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 3, 2022. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 01:12 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 3,564 | $59.75 Strike: $59.75 | $212,949.00 |
DisclosureSEC source: 0000096943-21-000087 · wf-form4_162622511103793.xml · derivative · entry 6 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,564 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2021. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 01:12 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 150 | $423.95 | $63,592.50 |
DisclosureSEC source: 0000096943-21-000087 · wf-form4_162622511103793.xml · nonDerivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,424.18 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $423.90 to $424.06. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 01:12 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 1,200 | $423.39 | $508,068.00 |
DisclosureSEC source: 0000096943-21-000087 · wf-form4_162622511103793.xml · nonDerivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574.18 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $422.89 to $423.775. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 01:12 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 2,214 | $422.00 | $934,308.00 |
DisclosureSEC source: 0000096943-21-000087 · wf-form4_162622511103793.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,774.18 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $421.665 to $422.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 01:12 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 3,564 | $59.75 | $212,949.00 |
DisclosureSEC source: 0000096943-21-000087 · wf-form4_162622511103793.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,988.18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2021. Read SEC document |
| May 04, 2021 Filed May 6, 2021 20:59 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 771 | $0.00 Strike: $412.68 | $0.00 |
DisclosureSEC source: 0000096943-21-000059 · wf-form4_162033472744683.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 Underlying: Common Stock · 771 shares Expires 2031-05-04 Read SEC document |
| May 04, 2021 Filed May 6, 2021 20:59 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-21-000059 · wf-form4_162033472744683.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,424.18 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 4, 2021. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 12:24 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000106 · wf-form4_160388783588327.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 12:24 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $361.38 | $72,276.00 |
DisclosureSEC source: 0000096943-20-000106 · wf-form4_160388783588327.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 12:24 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000106 · wf-form4_160388783588327.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 01:27 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000101 · wf-form4_160134285387033.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 01:27 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $326.15 | $65,230.00 |
DisclosureSEC source: 0000096943-20-000101 · wf-form4_160134285387033.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 01:27 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000101 · wf-form4_160134285387033.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:41 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000099 · wf-form4_159847446085908.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:41 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $373.74 | $74,748.00 |
DisclosureSEC source: 0000096943-20-000099 · wf-form4_159847446085908.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:41 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000099 · wf-form4_159847446085908.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 01:05 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000091 · wf-form4_159598470148880.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 01:05 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $386.35 | $77,270.00 |
DisclosureSEC source: 0000096943-20-000091 · wf-form4_159598470148880.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 01:05 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000091 · wf-form4_159598470148880.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:41 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000088 · wf-form4_159320407591851.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:41 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 200 | $356.07 | $71,214.00 |
DisclosureSEC source: 0000096943-20-000088 · wf-form4_159320407591851.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:41 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000088 · wf-form4_159320407591851.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:35 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000080 · wf-form4_159061170235254.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:35 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $375.14 | $75,028.00 |
DisclosureSEC source: 0000096943-20-000080 · wf-form4_159061170235254.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:35 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000080 · wf-form4_159061170235254.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:22 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000072 · wf-form4_158888655169606.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:22 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000072 · wf-form4_158888655169606.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 21:07 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000048 · wf-form4_158810805090993.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 21:07 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $342.26 | $68,452.00 |
DisclosureSEC source: 0000096943-20-000048 · wf-form4_158810805090993.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 21:07 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000048 · wf-form4_158810805090993.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.